Adenoviral expression of suppressor of cytokine signaling-1 reduces adenovirus vector-induced innate immune responses

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 4931-4938

  Sakurai, Haruna ^a,b   Tashiro, Katsuhisa ^a,b   Kawabata, Kenji ^a   Yamaguchi, Tomoko ^a,b   Sakurai, Fuminori ^a   Nakagawa, Shinsaku ^b   Mizuguchi, Hiroyuki ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYTOKINE; JANUS KINASE; LUCIFERASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SOCS1 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENETIC TRANSFECTION; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ADENOVIRUS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; TRANSGENE;

ADENOVIRIDAE; ANIMALS; CELL LINE; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; IMMUNITY, NATURAL; JANUS KINASES; MACROPHAGES; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSGENES;

EID: 44449133221     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.4931     Document Type: Article

References (38)

1. Nazir, S. A., and J. P. Metcalf. 2005. Innate immune response to adenovirus. J. Investig. Med. 53: 292-304.
2. Sakurai, H., K. Kawabata, F. Sakurai, S. Nakagawa, and H. Mizuguchi. Innate immune response induced by gene delivery vectors. Int. J. Pharm. In press.
3. Muruve, D. A. 2004. The innate immune response to adenovirus vectors. Hum. Gene Ther. 15: 1157-1166.
4. Liu, Q., and D. A. Muruve. 2003. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10: 935-940.
5. Jooss, K., and N. Chirmule. 2003. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther. 10: 955-963.
6. Chen, D., B. Murphy, R. Sung, and J. S. Bromberg. 2003. Adaptive and innate immune responses to gene transfer vectors: role of cytokines and chemokines in vector function. Gene Ther. 10: 991-998.
7. Roberts, D. M., A. Nanda, M. J. Havenga, P. Abbink, D. M. Lynch, B. A. Ewald, J. Liu, A. R. Thorner, P. E. Swanson, D. A. Gorgone, et al. 2006. Hexon-chi- maeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 441: 239 -243.
8. Palmer, D. J., and P. Ng. 2005. Helper-dependent adenoviral vectors for gene therapy. Hum. Gene Ther. 16: 1-16.
9. + cells by an adenovirus type 35 vector. Gene Ther. 10: 1041-1048.
10. Sakurai, F., K. Kawabata, and H. Mizuguchi. 2007. Adenovirus vectors composed of subgroup B adenoviruses. Curr. Gene Ther. 7: 229 -238.
11. Vogels, R., D. Zuijdgeest, R. van Rijnsoever, E. Hartkoorn, I. Damen, M. P. de Bethune, S. Kostense, G. Penders, N. Helmus, W. Koudstaal, et al. 2003. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 77: 8263-8271.
12. Farina, S. F., G. P. Gao, Z. Q. Xiang, J. J. Rux, R. M. Burnett, M. R. Alvira, J. Marsh, H. C. Ertl, and J. M. Wilson. 2001. Replication-defective vector based on a chimpanzee adenovirus. J. Virol. 75: 11603-11613.
13. Koizumi, N., T. Yamaguchi, K. Kawabata, F. Sakurai, S. T., Y. Watanabe, T. Hayakawa, and H. Mizuguchi. 2007. Fiber-modified adenovirus vectors decrease liver toxicity through reduced interleukin 6 production. J. Immunol. 178: 1767-1773.
14. Yamaguchi, T., K. Kawabata, N. Koizumi, F. Sakurai, K. Nakashima, H. Sakurai, T. Sasaki, N. Okada, K. Yamanishi, and H. Mizuguchi. 2007. Involvement of MyD88 and TLR9 in the innate immune response elicited by replication- incompetent adenovirus vectors. J. Immunol. Hum. Gene Ther. 18: 753-762.
15. Basner-Tschakarjan, E., E. Gaffal, M. O'Keeffe, D. Tormo, A. Limmer, H. Wagner, H. Hochrein, and T. Tuting. 2006. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-α production. J. Gene Med. 8: 1300 -1306.
16. De Geest, B., J. Snoeys, S. Van Linthout, J. Lievens, and D. Collen. 2005. Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone. Hum. Gene Ther. 16: 1439 -1451.
17. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921.
18. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, et al. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387: 921-924.
19. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, et al. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387: 924-929.
20. Starr, R., D. Metcalf, A. G. Elefanty, M. Brysha, T. A. Willson, N. A. Nicola, D. J. Hilton, and W. S. Alexander. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95: 14395-14399.
21. Naka, T., T. Matsumoto, M. Narazaki, M. Fujimoto, Y. Morita, Y. Ohsawa, H. Saito, T. Nagasawa, Y. Uchiyama, and T. Kishimoto. 1998. Accelerated ap- optosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95: 15577-15582.
22. Marine, J. C., D. J. Topham, C. McKay, D. Wang, E. Parganas, D. Stravopodis, A. Yoshimura, and J. N. Ihle. 1999. SOCS1 deficiency causes a lymphocyte- dependent perinatal lethality. Cell 98: 609-616.
23. Alexander, W. S., R. Starr, J. E. Fenner, C. L. Scott, E. Handman, N. S. Sprigg, J. E. Corbin, A. L. Cornish, R. Darwiche, C. M. Owczarek, et al. 1999. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597-608.
24. Shen, L., K. Evel-Kabler, R. Strube, and S. Y. Chen. 2004. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat. Biotechnol. 22: 1546-1553.
25. Hanada, T., H. Yoshida, S. Kato, K. Tanaka, K. Masutani, J. Tsukada, Y. Nomura, H. Mimata, M. Kubo, and A. Yoshimura. 2003. Suppressor of cy- tokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 19: 437-450.
26. Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS- induced macrophage activation. Immunity 17: 583-591.
27. Nakagawa, R., T. Naka, H. Tsutsui, M. Fujimoto, A. Kimura, T. Abe, E. Seki, S. Sato, O. Takeuchi, K. Takeda, et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17: 677-687.
28. Kimura, A., T. Naka, T. Muta, O. Takeuchi, S. Akira, I. Kawase, and T. Kishimoto. 2005. Suppressor of cytokine signaling-1 selectively inhibits LPS- induced IL-6 production by regulating JAK-STAT. Proc. Natl. Acad. Sci. USA 102: 17089 -17094.
29. Mizuguchi, H., N. Koizumi, T. Hosono, N. Utoguchi, Y. Watanabe, M. A. Kay, and T. Hayakawa. 2001. A simplified system for constructing recombinant ad-enoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther. 8: 730 -735.
30. Mizuguchi, H., and M. A. Kay. 1999. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Hum. Gene Ther. 10: 2013-2017.
31. Maizel, J. V., Jr., D. O. White, and M. D. Scharff. 1968. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36: 115-125.
32. Yoshimura, A., H. M. Ohishi, D. Aki, and T. Hanada. 2004. Regulation of TLR signaling and inflammation by SOCS family proteins. J. Leukocyte Biol. 75: 422-427.
33. Okugawa, S., Y. Ota, T. Kitazawa, K. Nakayama, S. Yanagimoto, K. Tsukada, M. Kawada, and S. Kimura. 2003. Janus kinase 2 is involved in lipopolysaccha- ride-induced activation of macrophages. Am. J. Physiol. 285: C399 -C408.
34. Sakurai, H., F. Sakurai, K. Kawabata, T. Sasaki, N. Koizumi, H. Huang, K. Tashiro, S. Kurachi, S. Nakagawa, and H. Mizuguchi. 2007. Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex. J Control Release 117: 430 -437.
35. Parker, A. L., S. N. Waddington, C. G. Nicol, D. M. Shayakhmetov, S. M. Buckley, L. Denby, G. Kemball-Cook, S. Ni, A. Lieber, J. H. McVey, et al. 2006. Multiple vitamin K-dependent coagulation zymogens promote adeno- virus-mediated gene delivery to hepatocytes. Blood 108: 2554-2561.
36. Schindler, C., D. E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282: 20059 -20063.
37. Manickan, E., J. S. Smith, J. Tian, T. L. Eggerman, J. N. Lozier, J. Muller, and A. P. Byrnes. 2006. Rapid Kupffer cell death after intravenous injection of ade- novirus vectors. Mol. Ther. 13: 108 -117.
38. Lieber, A., C. Y. He, L. Meuse, D. Schowalter, I. Kirillova, B. Winther, and M. A. Kay. 1997. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71: 8798 -8807.